Long-lasting and clinically proven solutions for bladder and bowel control

Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to improve the quality of life for patients suffering from urinary and bowel dysfunction.

OAB, FI, SUI solutions with Axonics SNM and Bulkamid
Axonics SNM

Axonics SNM offers a long-lasting therapy option that is easy-to-use and clinically proven to help people regain bladder and bowel control.1

AxonicsR15® Device AxonicsR15® Logo

Axonics SNM for bowel control

AxonicsR20® Device AxonicsR20® Logo

Axonics SNM for bladder control


The Bulkamid Advantage

Unique Composition

Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide2.

Precision Delivery System

Allows for reproducible placement of the Bulkamid cushions under direct vision.

Efficacious, Durable, Safe

92% of women report being cured or improved at 12 months2, with durability demonstrated at seven years3 and no serious adverse events4.


  1. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [published online ahead of print, 2021 Jan 28]. Neurourol Urodyn. 2021;10.1002/nau.24615. doi:10.1002/nau.24615
  2. Brosche T, et al. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Journal of Neurology and Urodynamics. 2021
  3. Dwyer et al., “Voice your choice”: A study of women’s choice of surgery for primary stress urinary incontinence. International Urogynecology Journal (2020) 31:769-777
  4. Itkonen Freitas et al. Tension free vaginal tape vs polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomised controlled trial. Journal of Urology 2020
Emergo Europe B.V. Westervoortsedijk 60
6827 AT Arnhem The Netherlands


We are here to help answer any questions you may have about Axonics Therapy.